Swiss Chems

A research-chemical vendor selling peptides and SARMs with open carts and third-party test reports. An FDA warning letter names it.

Passes 4 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1, August 2026.

Dispositions at a glance

Code	Criterion	Disposition
S1	Prescriber requirement	FAIL
S2	Prescription gating	FAIL
S3	Pharmacy identification	FAIL
S4	Compounding disclosure	PASS
S5	Analytical documentation	PASS
S6	Business address	NOT VERIFIED
S7	Price disclosure	PASS
S8	Enforcement status	PASS

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1FAILNo clinician appears anywhere on the pages read. Sales involve no prescriber.Source: swisschems.is · read August 2026.

S2FAILProducts add to cart directly. The only gate is an age attestation.Source: swisschems.is/term-conditions · read August 2026.

S3FAILNo pharmacy involvement is claimed anywhere on the pages read.Source: swisschems.is · read August 2026.

S4PASSSells no compounded drugs; every page states research use only, not for human consumption.Source: swisschems.is/term-conditions · read August 2026.

S5PASSThird-party test reports published per product, principally from Janoshik Analytical.Source: swisschems.is/independent-test-results · read August 2026.

S6NOT VERIFIEDNo street address appeared on the pages read, and a request for the contact page did not resolve on 2026-08-31, which returned an access block. The check is open.Source: swisschems.is/contact · read August 2026.

S7PASSPrices are printed on every product page, with no account or intake required.Source: swisschems.is · read August 2026.

S8PASSFDA warning letter 695663, December 2024, names Swisschems over unapproved semaglutide and retatrutide offered from this domain. No close-out letter appears in the index. No FDA action has halted the business, and the store still trades.Source: fda.gov, letter 695663 · read August 2026.

Products shown on the seller's own pages at the recorded date: BPC-157, TB-500, KPV, Semax, Epitalon, DSIP, MOTS-c, NAD+, sermorelin, SARMs.

Sellers passing S1, prescriber requirement · every record below dated August 2026

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1, August 2026. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.